Actavis PLC (NYSE:ACT)

289.78
Delayed Data
As of Feb 26
 -0.62 / -0.21%
Today’s Change
184.71
Today|||52-Week Range
296.77
+12.58%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$77.3B

Company Description

Actavis plc operates as an investment holding company. It is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, brand generic, over-the-counter and biosimilar products. The company was founded on October 1, 2013 and is headquartered in Dublin, Ireland.

Contact Information

Actavis Plc
1 Grand Canal Square
Dublin Dublin 2
P:(951) 493-5300
Investor Relations:
(862) 261-7152

Employees

Shareholders

Other institutional48.34%
Mutual fund holders47.98%
Individual stakeholders0.42%

Top Executives

Brenton L. SaundersPresident, Chief Executive Officer & Director
Robert A. StewartChief Operating Officer
Maria Teresa HiladoChief Financial Officer
James DareccaChief Accounting Officer & Vice President
Hafrun FridriksdottirSVP-Generics Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account